相关实验视频

Updated: Sep 9, 2025

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs

Published on: July 12, 2022

左心室重塑指数用于预测扩大心肌病中的心室动脉节律

Xi Jia¹, Weipeng Yan¹, Xuan Ma¹

¹Department of Magnetic Resonance Imaging, Fuwai Hospital, National Center for Cardiovascular Diseases of China, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Insights into imaging

|August 29, 2025

概括

左心室重塑指数 (LVRI) 预测了扩张性心肌病 (DCM) 患者的腹腔动脉节律 (VTA). 7. 5或更高的LVRI与致命的VTA事件有关,比标准的心脏MRI指标更有价值.

科学领域:

心脏病学
医学成像
生物医学工程

背景情况:

扩张性心肌病 (DCM) 的特征是左心室 (LV) 功能障碍和重塑.
患有DCM的患者左心室喷射分数 (LVEF) 低于35%,患上心室动脉节律失常 (VTA) 的风险较高.
这种人群中VTA的预测标记对于及时干预至关重要.

研究的目的:

评估左心室重塑指数 (LVRI) 作为DCM患者LVEF< 35%的VTA预测指数.
确定LVRI是否比传统的心磁共振 (CMR) 参数提供增量预后值.

主要方法:

对271名接受CMR的DCM患者进行了回顾性分析,LVEF< 35%.
LVRI 计算为 LV 末端透析体积的立方根除最大 LV 壁厚.
用于评估LVRI和VTA事件之间的关联的Kaplan- Meier和竞争风险回归分析.

主要成果:

在平均71个月的随访期间,35名患者出现了静脉动脉事件.
LVRI≥7. 5与静脉动脉风险的增加显著相关 (p < 0. 0001).
在多变量分析中,LVRI ≥ 7. 5独立预测VTA (HR 2. 496, p = 0. 013),即使调整了年龄,性别和左捆分支.

结论:

在非缺血性DCM患者的LVEF< 35%中,LVRI是致命静脉动脉的重要独立预测指标.
一个7. 5的LVRI值显示出预后价值,超过传统的CMR指标.
需要进一步的多中心验证,以评估LVRI在可植入心脏变压器决策中的作用.

关键词:

心脏磁共振扩张性心肌病改造指数腹腔动脉节律失常

更多相关视频

Histological Quantification of Chronic Myocardial Infarct in Rats

Histological Quantification of Chronic Myocardial Infarct in Rats

Published on: December 11, 2016

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography

Published on: February 16, 2016

相关概念视频

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...